miglustat has been researched along with Escherichia coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butters, T; Dwek, R; Frendeus, B; Platt, F; Svanborg, C; Svensson, M | 1 |
| Platt, FM; Svanborg, C; Svensson, M | 1 |
1 review(s) available for miglustat and Escherichia coli Infections
| Article | Year |
|---|---|
Glycolipid receptor depletion as an approach to specific antimicrobial therapy.
Topics: 1-Deoxynojirimycin; Animals; Bacterial Adhesion; Escherichia coli Infections; Glycosphingolipids; Humans; Immunity, Innate; Lysosomal Storage Diseases; Receptors, Cell Surface; Urinary Tract Infections | 2006 |
1 other study(ies) available for miglustat and Escherichia coli Infections
| Article | Year |
|---|---|
Glycolipid depletion in antimicrobial therapy.
Topics: 1-Deoxynojirimycin; Animals; Bacterial Adhesion; Cell Line; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Fimbriae, Bacterial; Glycosphingolipids; Humans; Mice; Mice, Inbred C3H; Receptors, Cell Surface; Recombinant Proteins; Urinary Tract Infections | 2003 |